Riskpilot← Back to searchSign inGet full accessHT Simonsen Holding ApS
APSActiveCVR 37334308Kæraasen 19Activities of holding companies · NACE 6421Est. 2016— employees
Revenue 2024
DKK -477
-109% vs 2023
EBITDA margin
100.0%
-336% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK -477
-109% vs 2023
| Revenue | DKK -477 | -109% |
| EBITDA | DKK -477 | -336% |
| Net profit | DKK -477 | -109% |
| Total assets | DKK 15K | -35% |
| Equity | DKK 15K | -35% |
| Employees | — | — |
Legal name
HT Simonsen Holding ApS
CVR number
37334308
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
2. januar 2016
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør
Company purpose
Selskabets formål er at være holdingselskab for datterselskaber, der driver bioteknologisk eller lign virksomhed. Selskabets formål omfatter endvidere at eje kapitalandele i andre virksomheder, anbringelse af kapital i faste ejendomme, og i øvrigt enhver anden virksomhed, der efter bestyrelsens skøn står i forbindelse hermed.
Address
Kæraasen 19
Phone
+4526986684
Email
henriktoftsimonsen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -30 | -2 | 0 | 5 | -0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -30 | -2 | -10 | 0 | -0 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -30 | -2 | -10 | 0 | -0 |
| Net financials | 0 | 15 | -0 | 5 | 0 |
| Profit before tax | -30 | 13 | -10 | 5 | -0 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -30 | 13 | -10 | 5 | -0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 | 48 | 31 | 23 | 15 |
| Equity | 2 | 48 | 31 | 23 | 15 |
| Long-term debt | 2 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 |
| Total debt | 2 | 0 | 0 | 0 | 0 |
EBITDA margin
-47700.0%
This company
15.8%
Market median
-301999% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
-3.3%
This company
18.4%
Market median
-118% vs market
20202024
Net profit margin
-47700.0%
This company
8.1%
Market median
-588989% vs market
20202024
Asset turnover
-0.03×
This company
1.12×
Market median
-103% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
HB Management | Management | 2016 – 2016 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HT Simonsen Holding ApS 
Tailwind Biotech ApSBoard members of HT Simonsen Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hansol Bae | Management | 0 companies |